Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

578
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
578
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

704
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
704
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

677
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
677
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

551
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
551
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

658
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
658

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Direct, transapical, echocardiography-guided laceration of an Alfieri stitch to facilitate transcatheter mitral valve implantation: Keeping it simple.

JTCVS structural and endovascular·2026
Same author

Stem-Cell-Derived Biologic Ventricular Assist Tissue in Heart Failure.

The New England journal of medicine·2026
Same author

Manual long axis strain compared to automated feature-tracking deformation imaging for identification of masked left heart involvement in pulmonary hypertension.

The international journal of cardiovascular imaging·2026
Same author

Impact of a Clinical Valve Coordinator on Hospital Length of Stay and Patient Outcomes: Results From the BENCHMARK Registry.

Structural heart : the journal of the Heart Team·2026
Same author

Calculation of pulmonary capillary wedge pressure including left atrial function is superior to morphology alone and accurately identifies elevated filling pressures in left heart disease.

Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance·2025
Same author

Right Atrial Contraction Strain Is Associated With Clinically Significant Cellular Rejection in Patients After Heart Transplantation.

Transplant international : official journal of the European Society for Organ Transplantation·2025

相关实验视频

Updated: Mar 3, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.3K

[关于多变性心肌病的更新]

Andreas J Rieth1, Tim Seidler2

  • 1Abteilung Kardiologie, Kerckhoff-Klinik, Benekestr. 2-8, 61231, Bad Nauheim, Deutschland. a.rieth@kerckhoff-klinik.de.

Innere Medizin (Heidelberg, Germany)
|March 2, 2026
PubMed
概括

超性心肌病 (HCM) 包括遗传和获得的形式. 诊断包括成像和遗传检测,风险分层和针对性治疗可用于原发性HCM和跨甲基氨基酸心肌病.

科学领域:

  • 心脏病学 心脏病学
  • 遗传学 遗传学 是一个
  • 医疗成像医学成像

背景情况:

  • 在欧洲,多变性心肌病 (HCM) 包括原发性遗传和继发性获得形式.
  • 区分这些形式对于适当的管理至关重要.
  • 左心室壁加厚需要差异诊断以确定潜在原因.

研究的目的:

  • 概述超性心肌病 (HCM) 的诊断方法.
  • 突出高级成像和基因检测在HCM诊断中的作用.
  • 讨论不同HCM亚型的当前治疗策略.

主要方法:

  • 心声扫描用于初步评估左心室壁加厚的情况.
  • 心脏磁共振成像 (CMR) 用于确定诊断.
  • 基因检测用于识别主要的HCM病因.
  • 在初级HCM患者心律不整的风险分层.

主要成果:

  • 而CMR是确定HCM诊断的关键.
  • 基因检测对初级HCM,特别是常见形式很重要.
  • 对初级HCM来说,心律失常风险分层是强制性的.
  • 对于症状性阻塞和跨氨酸氨基酸心肌病有特殊的治疗方法.
关键词:
粉样性心肌病变性心脏病心脏衰竭是因为心脏衰竭.过敏性心肌病变性/差异诊断的不同.左心室外流管阻塞 阻塞左心室外流管肌酸酶抑制可以抑制肌酸酶.

更多相关视频

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

6.3K
Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
14:39

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples

Published on: April 21, 2014

18.0K

相关实验视频

Last Updated: Mar 3, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.3K
An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

6.3K
Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
14:39

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples

Published on: April 21, 2014

18.0K

结论:

  • 一个系统的诊断途径,包括心声学,CMR和基因检测,对于HCM是必不可少的.
  • 风险分层和向疗法改善了原发性HCM和二次形式 (如西氨基酸心肌病) 的结果.